Related Experiment Videos
[Approximation to conservative surgery of Leydig cell tumor]
J L Pobil Moreno1, J Martínez Rodríguez, J L Maestro Durán
1Servicio de Urología, Hospital Universitario Virgen del Rocío, Sevilla, España.
Archivos Espanoles De Urologia
|September 1, 1996
Summary
Conservative surgery for Leydig cell tumors (LCTs) is feasible. Parenchyma-sparing approaches like tumorectomy offer oncological safety and preserve endocrine function, especially in young males.
Area of Science:
- Urology
- Endocrinology
- Oncology
Background:
- Leydig cell tumors (LCTs) are rare testicular neoplasms.
- Clinical presentation can include feminizing features or hypogonadism.
Purpose of the Study:
- To analyze clinical and histological features of LCTs.
- To establish criteria for conservative surgical management.
Main Methods:
- Retrospective analysis of 5 LCT cases (16.1% of 31 testicular tumors).
- Evaluation of patient demographics, clinical signs (feminizing, hypogonadal), and histopathology.
- Assessment of tumor aggressiveness indicators.
Main Results:
- No metastasis observed during a mean follow-up of 522.9 months.
- Three patients underwent radical orchidectomy.
- One patient treated with tumorectomy remained tumor-free for over 120 months.
Conclusions:
- Parenchyma-sparing surgery (tumorectomy) is a viable option for select LCTs.
- Conservative management offers endocrinological and psychological benefits.
- Criteria for conservative surgery should focus on clinical and histological indicators of non-aggression.